Neoadjuvant Zoledronate and Atorvastatin in Triple Negative Breast Cancer (YAPPETIZER)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03358017 |
Recruitment Status :
Completed
First Posted : November 30, 2017
Last Update Posted : October 19, 2023
|
Sponsor:
Mario Negri Institute for Pharmacological Research
Collaborator:
Associazione Italiana per la Ricerca sul Cancro
Information provided by (Responsible Party):
Mario Negri Institute for Pharmacological Research
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | June 17, 2021 |
Actual Study Completion Date : | July 25, 2023 |
Publications: